E. Nagore et al., Analysis of the CDKN2A and CDK4 genes and HLA-DR and HLA-DQ alleles in twoSpanish familial melanoma kindreds, ACT DER-VEN, 80(6), 2000, pp. 440-442
Some confusion exists in the literature about which criteria should be used
to define familial melanoma, This could explain the different reported fre
quencies of mutations in predisposing genes, mostly CDKN2A, in these patien
ts. This study evaluated the human leucocyte antigen (HLA) class II genotyp
e and the presence of mutations in CDKN2A and CDK4 genes in 2 families with
very different clinical features. The family with a germinal mutation in e
xon 2 of CDKN2A (Gly(101)Try) presented the following clinical features: 3
first-degree affected members, I of whom had 2 melanomas, and all the melan
omas appearing before 35 years of age. In contrast, the second family did n
ot present any mutation in the studied genes and included 2 first-degree af
fected members diagnosed at over 45 years of age. Neither family showed an
association with HLA genotype, Other genes are also involved in familial me
lanoma but, when the CDKN2A gene is affected, some clinical features seem t
o be uniform.